{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:48:28Z","timestamp":1794851308230,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","award":["T11-705\/21-N"],"award-info":[{"award-number":["T11-705\/21-N"]}],"id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","award":["HKU SRFS2021-7S03"],"award-info":[{"award-number":["HKU SRFS2021-7S03"]}],"id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022720","name":"Health Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"HMRF","doi-asserted-by":"publisher","award":["INF-HKU-3"],"award-info":[{"award-number":["INF-HKU-3"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.vaccine.2026.128262","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:28:25Z","timestamp":1769174905000},"page":"128262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Estimates of SARS-CoV-2 vaccine effectiveness against COVID-19-associated hospitalisation in paediatric patients in Hong Kong during two successive SARS-CoV-2 epidemic waves dominated by the Omicron variant: A test-negative design study"],"prefix":"10.1016","volume":"75","author":[{"given":"George N.","family":"Okoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike Y.W.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice L.Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitriona","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Lun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128262_bb0005","article-title":"Effectiveness of COVID-19 vaccines against hospitalisation in Latin America during three pandemic waves, 2021-2022: a test-negative case-control design","volume":"27","author":"Nogareda","year":"2023","journal-title":"Lancet Reg Health Am"},{"issue":"10285","key":"10.1016\/j.vaccine.2026.128262_bb0010","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0140-6736(21)00677-2","article-title":"Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study","volume":"397","author":"Vasileiou","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128262_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.15985","article-title":"Assessment of effectiveness of 1 dose of BNT162b2 vaccine for SARS-CoV-2 infection 13 to 24 days after immunization","volume":"4","author":"Chodick","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2026.128262_bb0020","article-title":"Vaccination reduces need for emergency care in breakthrough COVID-19 infections: a multicenter cohort study","volume":"4","author":"Bahl","year":"2021","journal-title":"Lancet Reg Health Am"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128262_bb0025","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/cid\/ciac634","article-title":"Effectiveness of coronavirus disease 2019 vaccines against hospitalization and death in Canada: a multiprovincial, test-negative design study","volume":"76","author":"Nasreen","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128262_bb0030","doi-asserted-by":"crossref","first-page":"7336309","DOI":"10.1155\/2022\/7336309","article-title":"Emergence of SARS-CoV-2 new variants and their clinical significance","volume":"2022","author":"Singh","year":"2022","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128262_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msac013","article-title":"The emergence of SARS-CoV-2 variants of concern is driven by acceleration of the substitution rate","volume":"39","author":"Tay","year":"2022","journal-title":"Mol Biol Evol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128262_bb0040","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128262_bb0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(23)00140-6","article-title":"COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint","volume":"11","author":"Zaeck","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"16","key":"10.1016\/j.vaccine.2026.128262_bb0050","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"issue":"42","key":"10.1016\/j.vaccine.2026.128262_bb0055","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.15585\/mmwr.mm7242e1","article-title":"Use of updated COVID-19 vaccines 2023\u20132024 formula for persons aged \u22656 months: recommendations of the advisory committee on immunization practices \u2014 United States, September 2023","volume":"72","author":"Regan","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128262_bb0060","article-title":"Development of COVID-19 vaccine policy - United States, 2020-2023","volume":"42","author":"Oliver","year":"2024","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128262_bb0065","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/jama.2021.2294","article-title":"SARS-CoV-2 variants of concern in the United States-challenges and opportunities","volume":"325","author":"Walensky","year":"2021","journal-title":"JAMA"},{"issue":"44","key":"10.1016\/j.vaccine.2026.128262_bb0070","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1016\/j.vaccine.2023.07.037","article-title":"A summary of the advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States","volume":"41","author":"Wallace","year":"2023","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128262_bb0075","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1016\/S2666-5247(23)00216-1","article-title":"Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial","volume":"4","author":"Leung","year":"2023","journal-title":"Lancet Microbe"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128262_bb0080","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jpids\/piad083","article-title":"Influenza vaccine effectiveness against influenza-associated hospitalization in Hong Kong children aged 9 months to 17 years, march-June 2023","volume":"12","author":"Cowling","year":"2023","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128262_bb0085","doi-asserted-by":"crossref","first-page":"2185455","DOI":"10.1080\/22221751.2023.2185455","article-title":"Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study","volume":"12","author":"Yan","year":"2023","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128262_bb0090","article-title":"COVID-19 vaccines versus pediatric hospitalization","volume":"4","author":"Rosa Duque","year":"2023","journal-title":"Cell Rep Med"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128262_bb0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/kww064","article-title":"Theoretical basis of the test-negative study Design for Assessment of influenza vaccine effectiveness","volume":"184","author":"Sullivan","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"9596","key":"10.1016\/j.vaccine.2026.128262_bb0100","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128262_bb0105","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1093\/cid\/ciac234","article-title":"Effects of confounding Bias in coronavirus disease 2019 (COVID-19) and influenza vaccine effectiveness test-negative designs due to correlated influenza and COVID-19 vaccination Behaviors","volume":"75","author":"Doll","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128262_bb0110","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/oxfordjournals.aje.a009196","article-title":"Study designs for evaluating different efficacy and effectiveness aspects of vaccines","volume":"146","author":"Halloran","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128262_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/v15010167","article-title":"A detailed overview of SARS-CoV-2 omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and therapies","volume":"15","author":"Chatterjee","year":"2023","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128262_bb0120","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1056\/NEJMc2214314","article-title":"Substantial neutralization escape by SARS-CoV-2 omicron variants BQ.1.1 and XBB.1","volume":"388","author":"Miller","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128262_bb0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"issue":"218","key":"10.1016\/j.vaccine.2026.128262_bb0130","article-title":"Reactogenicity and safety of COVID-19 primary immunisation and booster vaccination regimens: a comparative observational cohort study","volume":"21","author":"Warkentin","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2026.128262_bb0135","unstructured":"Strategic Advisory Group of Experts on Immunization. SAGE updates COVID-19 vaccination guidance. World Health Organization. https:\/\/www.who.int\/news\/item\/28-03-2023-sage-updates-covid-19-vaccination-guidance. Published 2023. Accessed April 9, 2024."},{"issue":"14","key":"10.1016\/j.vaccine.2026.128262_bb0140","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1016\/j.vaccine.2024.04.035","article-title":"Assessment of the impact of the vaccine pass policy on COVID-19 vaccine hesitancy and uptake among Chinese adults in Hong Kong","volume":"42","author":"Wong","year":"2024","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128262_bb0145","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa2117995","article-title":"Effectiveness of BNT162b2 vaccine against critical Covid-19 in adolescents","volume":"386","author":"Olson","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128262_bb0150","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJMoa2203209","article-title":"Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age","volume":"387","author":"Tan","year":"2022","journal-title":"N Engl J Med"},{"issue":"5690","key":"10.1016\/j.vaccine.2026.128262_bb0155","article-title":"Effectiveness of COVID-19 vaccines among children 6\u201311 years against hospitalization during omicron predominance in Malaysia","volume":"14","author":"Jayaraj","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.128262_bb0160","article-title":"Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the omicron outbreak in Argentina: a retrospective cohort study","volume":"13","author":"Gonzalez","year":"2022","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128262_bb0165","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1038\/s41467-022-32524-5","article-title":"Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the omicron period","volume":"13","author":"Florentino","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128262_bb0170","article-title":"The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: a case study in Hong Kong","volume":"13","author":"Yang","year":"2021","journal-title":"Lancet Reg Health West Pac"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:50:43Z","timestamp":1773993043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"alternative-id":["S0264410X26000691"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128262","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimates of SARS-CoV-2 vaccine effectiveness against COVID-19-associated hospitalisation in paediatric patients in Hong Kong during two successive SARS-CoV-2 epidemic waves dominated by the Omicron variant: A test-negative design study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128262"}}